Can my child use the new over-the-counter glucose monitor without a prescription?
The FDA cleared the first over-the-counter continuous glucose monitor for children on June 12, 2026. It is for kids age 2 and older who do not use insulin, but it is not right for every child and cannot replace medical evaluation when symptoms are concerning.
Yes, some children can use the newly cleared over-the-counter glucose monitor without a prescription. On June 12, 2026, the FDA cleared Dexcom’s Stelo Glucose Biosensor System for children age 2 and older who do not use insulin, making it the first OTC continuous glucose monitor cleared for pediatric use in the United States. (FDA)
The practical bottom line for families is simple: this may be a useful tracking tool for some children, but it is not a substitute for a medical evaluation, a diagnosis, or clinician-directed diabetes care when a child has symptoms or already uses insulin. (FDA)
What changed
Before this action, the device had been cleared over the counter for adults. The new FDA decision expands use to children age 2 and older who do not use insulin. The device uses a small wearable sensor and a smartphone app that can be viewed on a parent’s or caregiver’s phone. The sensor is designed to last up to 15 days. (FDA)
What a continuous glucose monitor actually does
A continuous glucose monitor, or CGM, is not the same as a one-time fingerstick. It uses a tiny sensor under the skin to measure glucose in interstitial fluid and sends readings throughout the day. The CDC says CGMs can help people see patterns related to meals, activity, and daily routines. (CDC)
CGM numbers are not identical to a blood test. The CDC notes that interstitial glucose can differ from blood glucose, and people may still need fingersticks at times to check accuracy, especially when they are new to CGM use. That is one reason families should think of this OTC device as a monitoring tool, not a way to diagnose or rule out diabetes at home. (CDC)
Who can use it, and who should not
The FDA clearance is limited to children age 2 and older who do not use insulin. The agency also says children should use the device under adult supervision. For some families, that may make it easier to watch how meals, activity, and other daily routines affect glucose patterns. (FDA)
This is not the right product for every child. The FDA says it is not for people with problematic hypoglycemia because it is not designed to alert users to dangerous low blood sugar. It is also not for people on dialysis. Families should also be cautious if a child has a history of disordered eating or an eating disorder and should talk with a clinician first. (FDA)
Children with type 1 diabetes, insulin-treated type 2 diabetes, or other complex diabetes care needs should not assume an OTC sensor can replace prescription diabetes technology or an existing care plan. Current American Diabetes Association standards support CGM use in children and adolescents with diabetes when it can be used safely, but that is still part of clinician-directed care. (American Diabetes Association)
What it can and cannot do
For the right family, an OTC CGM may make glucose trends easier to see without repeated fingersticks. It may also help parents bring better information to a pediatrician visit. But the device does not replace diagnosis, treatment planning, or emergency care. (CDC, FDA)
There are important limits. The FDA says users should talk with a health care provider before making medication changes based on the readings. The device does not provide low-glucose alerts for dangerous hypoglycemia, and it should not be used as a do-it-yourself shortcut when a child has symptoms that need testing and medical care. (FDA)
When not to wait for an appointment
If a child has symptoms that could point to diabetes, do not rely on an OTC monitor alone. The CDC says symptoms can include frequent urination, increased thirst or hunger, weight loss without trying, fatigue, irritability, and blurry vision. (CDC)
Get urgent medical help right away if there is concern for diabetic ketoacidosis, or DKA. MedlinePlus describes DKA as a life-threatening problem and lists warning signs such as nausea and vomiting, stomach pain, deep rapid breathing, dehydration, fruity-smelling breath, and decreased alertness. (MedlinePlus)
What families can do next
- If your child already uses insulin or has diagnosed diabetes, do not switch devices or change treatment on your own; check with your diabetes care team first. (FDA)
- If your child has new symptoms, call the pediatrician promptly and ask about proper diabetes testing rather than trying to figure it out only with an OTC sensor. (CDC)
- If you are considering this device for general glucose awareness, read the product instructions carefully and plan on adult supervision. (FDA)
- If readings do not match how your child looks or feels, do not ignore the symptoms. The CDC says fingerstick checks may still be needed, and symptoms deserve medical attention. (CDC)
For some families, this new OTC option may make glucose tracking more accessible and less intimidating. But the safest way to use that convenience is to keep it in perspective: it can add information, but it does not replace diagnosis, emergency care, or a child’s established diabetes treatment plan. (FDA)
Sources
Editorial note: Weence articles are researched from cited public-health, medical, regulatory, journal, and reputable news sources and may be drafted with AI assistance. They are checked for source support, clarity, and safety guardrails before publication.
This article is for general informational purposes only and is not medical advice. Research findings can be early or incomplete, and health guidance can change. Always talk with a qualified healthcare professional about personal symptoms, diagnosis, medications, vaccines, screenings, or treatment decisions. If you think you may have a medical emergency, call emergency services right away.
